Fierce Pharma Fierce Pharma
Webinar

Learning the Lessons of Failure: How to improve the economics of Life Sciences R&D

Available on-demand
60 Minutes

Join us for an insightful webinar where Clarivate experts delve into the costly reality of failed drug and device launches within the pharmaceutical industry. With approximately 90% of candidates entering clinical trials failing to achieve regulatory approval, understanding the reasons behind these failures is crucial for companies aiming to future-proof their product candidates.

What you'll learn:

  • Explore the significant costs associated with failed drug and device launches, and the impact on pharmaceutical companies.
  • Gain insights from real-world examples of drugs and devices such as bortezomib (Velcade), inhaled insulin (Exubera), Ionapegsomatropin (Sytrofa) and many more.
  • How to navigate challenges from early R&D through to commercialization, avoiding common pitfalls and maximizing the potential for success.

Speakers

Clarivate

Mike Ward

As both a journalist and analyst, Mike has been writing, analyzing and commenting on the life sciences industry for more than 35 years. His actionable insights and analysis support pharma, biotech, healthcare and medtech stakeholders gain a deeper understanding of market news and trends.

Dee Chaudary

Dee Chaudhary

With over 20 years of experience in the biopharmaceutical industry and life sciences consulting, Dee Chaudhary, a Principal at Clarivate Commercial Strategy Consulting, is a seasoned professional. Specializing in launch readiness, patient support services, billing and coding requirements for Pharma and MedTech, and market access strategy, Dee brings a wealth of knowledge in Medicare/Medicaid, 340B pricing, reimbursement strategy, and product positioning. Dee has actively engaged in both internal and external AI and innovation initiatives, demonstrating a commitment to staying at the forefront of industry advancements.

Samantha Chesney

Samantha Chesney

Samantha Chesney, Lead Clinical Consultant with 15+ years' experience, excels in clinical trial design, protocol analysis, and leveraging Real World Data (RWD). Known for custom solutions to complex clinical challenges, she manages global clinical consulting development and US regulatory affairs. Samantha's expertise includes e-consent, genetic research, and patient enrolment strategies for large-scale projects. She drives innovation in trial optimization and digital health databases, contributing unique insights to data-driven client solutions.

Carolyn Finch

Carolyn Finch

Carolyn Finch is a Senior Solutions Consultant with more than 30 years’ experience in the patent and scientific information industry. Since 2008, Carolyn has worked with clients around the world, helping them to accelerate drug discovery and preclinical R&D. She holds a bachelor’s degree in Biology with European Studies (French) from the University of Sussex in England.

Angela Weidner

Angela Weidner

Angela (Angie) Weidner, Senior Product Manager at Clarivate, boasts over 20 years in pharmaceuticals, specializing in clinical solutions, notably in Oncology. With a background in data solutions and consulting, she offers a unique perspective to product management, ensuring client-centric enhancements. Angie's prior editorial experience informs her understanding of the clinical trial landscape, advocating for data-driven advancements to expedite life-saving treatments. Recognized for her client engagement and bespoke solutions, Angie holds a BSc in Psychobiology, anchoring her expertise in scientific rigor.

Sofia Ataide

Sofia Ataide

Senior Solutions Consultant for the LS&H practice of Clarivate, primarily focused on Regulatory, CMC and Clinical solutions; Sofia holds an MSc in Pharmaceutical Sciences and International Health Management.

Register here to watch on-demand!

Duration:
60 Minutes